Summary by Moomoo AI
Caisang Pharmaceutical Holdings Limited issued a notice on 22 April 2024 indicating that Silver Pegasus Investment Limited intends to privatize its pharmaceutical business by agreement. The privatisation proposal was first proposed in the Joint Announcement of 28 March 2024. In addition, Caisang Pharmaceuticals disclosed updates on its Share Rights Incentive Program, including the Share Option Incentive Plan approved on June 24, 2018 and the Initial Public Offering Possession Option Plan approved by the Shareholders' Resolution on January 22, 2021. Under these plans, the Company has issued new shares and share purchase options. As of the date of the announcement, the total number of shares issued in Caisang Pharmaceuticals is 628,474,132 shares and has 68,337,132 share options. The Board of Directors is responsible for the accuracy of the contents of the announcement and verifies, after reasonable enquiries, that the content of the announcement is not missing facts and does not lead to misrepresentation.